Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
作者： Andrea Lombardi Borgia , Italo Beria , Marina Caldarelli , Maria Gabriella Brasca , Francesco Casuscelli
DOI:
关键词:
摘要: The present invention relates to tricyclic pyrrolo derivatives of Formula (I), which modulate the activity protein kinases and are therefore useful in treating diseases caused by dysregulated kinase activity. also provides methods for preparing these compounds, pharmaceutical compositions comprising utilizing such compounds or containing them.
lens.org 参考文章(46)
Ilaria Candiani, Italo Beria, Annalisa Airoldi, Massimo Zampieri, Riccardo Frigerio, Plk inhibitor salts ,(2010)
Claudia Piutti, Antonella Ermoli, Daniela Faiardi, Francesco Casuscelli, Substituted pyrazolo-quinazoline derivatives as kinase inhibitors ,(2011)
Gabriella Traquandi, Matteo Salsa, Claudia Piutti, Italo Beria, Marina Caldarelli, Nicoletta Colombo, Isoxazolo-quinazolines as modulators of protein kinase activity ,(2011)
Barbara Valsasina, Italo Beria, Helena Posteri, Maria Gabriella Brasca, Michele Caruso, Ronald Ferguson, Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors ,(2007)
Paola Vianello, Gabriella Traquandi, Ermes Vanotti, Alessandra Scolaro, Barbara Forte, Maria Menichincheri, Francesco Casuscelli, Marina Caldarelli, Tricyclic indoles and (4,5-dihydro) indoles ,(2007)
Marina Ciomei, Angela Scaburri, Cdk inhibitor for the treatment of mesothelioma ,(2009)
Bernard Laffranchi, Angela Scaburri, Silvia Comis, Marina Ciomei, Maria Adele Pacciarini, Use of a kinase inhibitor for the treatment of thymoma ,(2010)
Marina Ciomei, Enrico Pesenti, Francesco Fiorentini, Use of a cdk inhibitor for the treatment of glioma ,(2009)
Richard M. Weier, Patrick Lennon, Serge G. Wolfson, Xiangdong Xu, Michael Clare, Suzanne Metz, Michael Vazquez, Tricyclic pyrazole derivatives for the treatment of inflammation ,(2003)
Guido Koch, Lászlo Révész, Achim Schlapbach, Heterocyclic compounds useful as mk2 inhibitors ,(2008)